Charles MA - Search Results

1

Insulin antibody responses after long-term intraperitoneal insulin administration via implantable programmable insulin delivery systems.

Olsen CL, Chan E, Turner DS, Iravani M, Nagy M, Selam JL, Wong ND, Waxman K, Charles MA. Olsen CL, et al. Among authors: charles ma. Diabetes Care. 1994 Mar;17(3):169-76. doi: 10.2337/diacare.17.3.169. Diabetes Care. 1994. PMID: 8174443

2

Comparison of intraperitoneal and subcutaneous insulin administration on lipids, apolipoproteins, fuel metabolites, and hormones in type I diabetes mellitus.

Selam JL, Kashyap M, Alberti KG, Lozano J, Hanna M, Turner D, Jeandidier N, Chan E, Charles MA. Selam JL, et al. Among authors: charles ma. Metabolism. 1989 Sep;38(9):908-12. doi: 10.1016/0026-0495(89)90240-0. Metabolism. 1989. PMID: 2671601

3

Macrophage-mediated islet cell cytotoxicity in BB rats.

Nagy MV, Chan EK, Teruya M, Forrest LE, Likhite V, Charles MA. Nagy MV, et al. Among authors: charles ma. Diabetes. 1989 Oct;38(10):1329-31. doi: 10.2337/diab.38.10.1329. Diabetes. 1989. PMID: 2676662

4

Cellular immune alterations associated with human insulin therapy.

Eichner HL, Lauritano AA, Woertz LL, Selam JL, Gupta S, Charles MA. Eichner HL, et al. Among authors: charles ma. Diabetes Res. 1988 Jul;8(3):111-5. Diabetes Res. 1988. PMID: 3067952

5

Reduction of severe hypoglycemic events in type I (insulin dependent) diabetic patients using continuous subcutaneous insulin infusion.

Eichner HL, Selam JL, Holleman CB, Worcester BR, Turner DS, Charles MA. Eichner HL, et al. Among authors: charles ma. Diabetes Res. 1988 Aug;8(4):189-93. Diabetes Res. 1988. PMID: 3148381 Clinical Trial.

6

Diagnostic procedures for catheter malfunction in programmable implantable intraperitoneal insulin infusion devices.

Olsen CL, Turner DS, Iravani M, Waxman K, Selam JL, Charles MA. Olsen CL, et al. Among authors: charles ma. Diabetes Care. 1995 Jan;18(1):70-6. doi: 10.2337/diacare.18.1.70. Diabetes Care. 1995. PMID: 7698051

7

The use of glipizide combined with intensive insulin treatment for the induction of remissions in new onset adult type I diabetes.

Selam JL, Woertz L, Lozano J, Robinson M, Chan E, Charles MA. Selam JL, et al. Among authors: charles ma. Autoimmunity. 1993;16(4):281-8. doi: 10.3109/08916939309014647. Autoimmunity. 1993. PMID: 8025207 Free article. Clinical Trial.

8

Long-term safety and efficacy of programmable implantable insulin delivery systems.

Olsen CL, Liu G, Iravani M, Nguyen S, Khourdadjian K, Turner DS, Waxman K, Selam JL, Charles MA. Olsen CL, et al. Among authors: charles ma. Int J Artif Organs. 1993 Dec;16(12):847-54. Int J Artif Organs. 1993. PMID: 8175202

9

Alterations in reverse cholesterol transport associated with programmable implantable intraperitoneal insulin delivery.

Selam JL, Kashyap ML, Gupta AK, Turner D, Wong ND, Lozano JL, Charles MA. Selam JL, et al. Among authors: charles ma. Metabolism. 1994 Jun;43(6):665-9. doi: 10.1016/0026-0495(94)90112-0. Metabolism. 1994. PMID: 8201953 Clinical Trial.

10

Implantable programmable insulin pumps for the treatment of diabetes.

Waxman K, Turner D, Nguyen ST, Selam JL, Charles MA. Waxman K, et al. Among authors: charles ma. Arch Surg. 1992 Sep;127(9):1032-6; discussion 1036-7. doi: 10.1001/archsurg.1992.01420090036006. Arch Surg. 1992. PMID: 1387526

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

573 results

Search Page

Filters